Prothena Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
176,677.00
293,579.00
370,586.00
386,923.00
417,620.00
427,659
Total Accounts Receivable
58.00
1,759.00
509.00
178.00
240.00
2
Other Current Assets
1,487.00
3,937.00
6,308.00
4,261.00
8,467.00
3,729
Total Current Assets
178,222.00
299,275.00
377,403.00
391,362.00
426,327.00
431,390
Net Property, Plant & Equipment
3,372.00
3,121.00
3,862.00
56,452.00
54,990.00
52,835
Total Investments and Advances
-
-
-
4,056.00
4,056.00
4,056
Other Assets
-
-
1,121.00
2,193.00
2,843.00
813
Total Assets
182,410.00
304,116.00
385,236.00
459,976.00
496,329.00
498,796
Accounts Payable
1,790.00
4,722.00
4,519.00
13,069.00
13,633.00
Income Tax Payable
184.00
57.00
-
378.00
311.00
Other Current Liabilities
5,432.00
7,260.00
17,697.00
27,628.00
23,427.00
Total Current Liabilities
7,406.00
12,039.00
22,216.00
41,075.00
37,371.00
Deferred Taxes
816.00
1,720.00
2,850.00
5,913.00
8,113.00
Other Liabilities
1,734.00
2,188.00
2,351.00
53,498.00
51,769.00
Total Liabilities
9,140.00
14,227.00
24,567.00
94,573.00
89,140.00
Common Equity (Total)
173,270.00
289,889.00
360,669.00
365,403.00
407,189.00
Total Shareholders' Equity
173,270.00
289,889.00
360,669.00
365,403.00
407,189.00
Total Equity
173,270.00
289,889.00
360,669.00
365,403.00
407,189.00
Liabilities & Shareholders' Equity
182,410.00
304,116.00
385,236.00
459,976.00
496,329.00

About Prothena

View Profile
Address
77 Sir John Rogersons Quay
Dun Laoghaire Dublin 2
Ireland
Employees -
Website http://www.prothena.com
Updated 07/08/2019
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland.